Tammi R. Lambert

Tammi R. Lambert serves as a key procurement professional within the W40M MRC0 West agency under the Department of the Army, responsible for acquiring critical medical readiness capabilities that support operational field medicine. She manages the acquisition of in-vitro diagnostic substances, surgical instrumentation, sterilization systems, and blood management solutions essential for high-acuity care in deployed environments. Her work ensures the agency maintains medical sovereignty by securing advanced, FDA-regulated technologies that enable rapid diagnostics and life-saving interventions on the battlefield. Lambert’s portfolio is strategically aligned with the Army’s mission to sustain combat-ready medical forces through timely, compliant, and technically rigorous contracting. She maintains consistent partnerships with leading medical technology providers including Roche Diagnostics Corporation, Cardinal Health 414, LLC, and Surgical Neuromonitoring Associates, Inc., reflecting a preference for established vendors with proven capabilities in clinical diagnostics and surgical support systems. Her contracting patterns demonstrate a balance between large-scale industrial suppliers and specialized niche contractors, particularly in trauma care and laboratory analytics. These relationships are built on performance history, regulatory compliance, and supply chain reliability, ensuring uninterrupted delivery of mission-critical medical assets. Lambert’s set-aside preferences reveal a balanced approach to socioeconomic contracting, with 58.3% of awards issued as open competitions and 25% awarded through 8(a) competed pathways. An additional 16.7% are allocated as total small business set-asides under FAR 19.5, indicating a deliberate effort to foster small business participation without compromising operational urgency or technical requirements. Her pattern reflects a strategic alignment with Army policy to promote diversity in the supplier base while maintaining readiness standards. Her primary procurement focus lies in NAICS 325413 (in-vitro diagnostic substance manufacturing) and 334516 (analytical laboratory instrument manufacturing), underscoring deep expertise in diagnostic chemistry, point-of-care testing, and laboratory automation. She also regularly procures services under NAICS 621399, reflecting engagement with specialized clinical support providers. Lambert’s domain expertise centers on the intersection of medical technology, field-deployable diagnostics, and sterile processing systems critical to modern military medicine.